Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 trial data: Route : Once-weekly subcutaneous injection Dose range studied : 0.5 mg to 12 mg weekly Optimal dose : 12 mg weekly showed maximum efficacy in Phase 2 Titration : Gradual dose escalation over several weeks to manage GI tolerability Tirzepatide Dosing# Established FDA-approved dosing: Route : Once-weekly subcutaneous injection Starting dose : 2.5 mg weekly for 4 weeks Maintenance range : 5 mg, 10 mg, or 15 mg weekly Titration : 2.5 mg increments every 4 weeks to target dose Available formulations : Prefilled pens (Mounjaro/Zepbound) Tirzepatide's established titration protocol and prefilled pen delivery system offer practical advantages in clinical use
In addition, a Tolerable Upper intake Level (TUL) of 600 g/day has been proposed for adults, including pregnant and lactating women [21]
Friendly and knowledgable staff that answers the phone
However, its role in non-steroidogenic cells remains poorly understood
